Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Suspended × NSCLC × Clear all

Phase

Status

Unknown 38 Recruiting 32 Completed 27 Not yet recruiting 18 Terminated 11 Active not recruiting 11 Withdrawn 3 Suspended 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 44 Breast Neoplasms 36 Prostatic Neoplasms 26 Colorectal Neoplasms 23 Carcinoma, Non-Small-Cell Lung 18 Lung Neoplasms 16 Neoplasm Metastasis 15 Glioblastoma 15 Brain Neoplasms 14 Pancreatic Neoplasms 13 Melanoma 13 Ovarian Neoplasms 12 Leukemia, Myeloid, Acute 12 Stomach Neoplasms 11 Carcinoma, Hepatocellular 10 Triple Negative Breast Neoplasms 9 Multiple Myeloma 9 Glioma 9 Carcinoma, Renal Cell 9 Myelodysplastic Syndromes 8 Precursor Cell Lymphoblastic Leukemia-Lymphoma 7 Rectal Neoplasms 6 Lymphoma 6 Leukemia 6 Head and Neck Neoplasms 6 Esophageal Neoplasms 6 Colonic Neoplasms 6 Uterine Cervical Neoplasms 5 Pain 5 Lymphoma, Large B-Cell, Diffuse 5

Interventions

HM781-36B 1 Docetaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05378763 2026-02-18

PINNACLE

Spectrum Pharmaceuticals, Inc

Phase 3 Suspended

NSCLC

Data powered by HemOnc (CC BY 4.0) Colophon ⚡